There was a problem loading this presentation. You may not have permission to view it.

You do not have permission to view this presentation.

Future developments in antimicrobial agents


An error occurred while loading this content.

Please refresh the page to try again.

Refresh Now
You previously started this content
Login or join to view
Click to Play

Future developments in antimicrobial agents

Professor David Livermore
Professor of Medical Microbiology, Norwich Medical School, University of East Anglia, UK

Professor David Livermore highlights increasing resistance and the major bacterial challenges we face. Beta-lactams, the most widely used antibiotic are losing their efficacy. However, there is hope for antimicorbial agents. Cefiderocol, murepavadin and gepotidacin/zoliflodacin all show promise in replacing spent antibiotics. Further, non-antibiotic approaches and improved molecular diagnostics, while not currently comprehensive, could revolutionise the field.